Bank of Montreal Can Lowers Stake in Merit Medical Systems, Inc. (MMSI)

Bank of Montreal Can cut its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 44.6% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 48,561 shares of the medical instruments supplier’s stock after selling 39,116 shares during the quarter. Bank of Montreal Can’s holdings in Merit Medical Systems were worth $2,098,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Merit Medical Systems by 4.5% in the second quarter. Vanguard Group Inc. now owns 4,374,628 shares of the medical instruments supplier’s stock valued at $166,893,000 after buying an additional 187,745 shares in the last quarter. State Street Corp increased its position in Merit Medical Systems by 9.9% in the second quarter. State Street Corp now owns 1,339,547 shares of the medical instruments supplier’s stock worth $51,105,000 after purchasing an additional 120,759 shares during the period. Northern Trust Corp increased its position in Merit Medical Systems by 17.7% in the second quarter. Northern Trust Corp now owns 665,032 shares of the medical instruments supplier’s stock worth $25,371,000 after purchasing an additional 100,076 shares during the period. Eagle Asset Management Inc. increased its position in Merit Medical Systems by 2.0% in the third quarter. Eagle Asset Management Inc. now owns 605,511 shares of the medical instruments supplier’s stock worth $26,703,000 after purchasing an additional 11,779 shares during the period. Finally, Russell Investments Group Ltd. increased its position in Merit Medical Systems by 52.9% in the third quarter. Russell Investments Group Ltd. now owns 549,237 shares of the medical instruments supplier’s stock worth $23,261,000 after purchasing an additional 190,042 shares during the period. Institutional investors own 87.98% of the company’s stock.

Merit Medical Systems, Inc. (NASDAQ:MMSI) opened at $42.65 on Monday. The company has a current ratio of 2.78, a quick ratio of 1.43 and a debt-to-equity ratio of 0.39. Merit Medical Systems, Inc. has a 1-year low of $27.08 and a 1-year high of $48.10. The stock has a market capitalization of $2,140.99, a PE ratio of 69.92, a price-to-earnings-growth ratio of 2.53 and a beta of 1.29.

In other Merit Medical Systems news, Director Franklin J. Miller sold 10,000 shares of the firm’s stock in a transaction dated Friday, December 29th. The stock was sold at an average price of $43.93, for a total transaction of $439,300.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Kent W. Stanger sold 9,082 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $44.90, for a total value of $407,781.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 32,000 shares of company stock worth $1,416,379. Company insiders own 5.00% of the company’s stock.

A number of brokerages recently commented on MMSI. BidaskClub lowered Merit Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, January 26th. ValuEngine lowered Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Canaccord Genuity lifted their price objective on Merit Medical Systems from $45.00 to $47.50 and gave the stock a “buy” rating in a research report on Thursday, October 26th. Zacks Investment Research lowered Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, January 25th. Finally, SunTrust Banks set a $47.00 price objective on Merit Medical Systems and gave the stock a “buy” rating in a research report on Thursday, November 16th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and ten have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $43.77.

TRADEMARK VIOLATION NOTICE: This news story was published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.com-unik.info/2018/02/12/bank-of-montreal-can-lowers-stake-in-merit-medical-systems-inc-mmsi.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit